Oxa(thia)zolidine derivative and anti-inflammatory drug
AssigneeNippon Soda Co., Ltd.
InventorsMasae Takagi, Keiichi Ishimitsu, Tadayuki Nishibe
Life of this patent
Estimating the term…
Loading patent…
AssigneeNippon Soda Co., Ltd.
InventorsMasae Takagi, Keiichi Ishimitsu, Tadayuki Nishibe
Estimating the term…
The present invention provides medicinal compositions characterized by containing as the active ingredient either a compound represented by a general formula (1) or a pharmaceutically acceptable composite thereof, 1 [wherein X represents oxygen or sulfur; R1 represents hydrogen, C1-4 alkyl, etc.; R2 represents, e.g., phenyl optionally substituted by A1; R3 represents, e.g., hydrogen, C1-4 alkyl optionally substituted by A2, or a group represented by either one of the following formulae; 2 R represents oxygen, sulfur, or a group represented by a formula (N—G)], in particular, inhibitors of phospholipase A(2) activity; use of the compositions; and compounds represented by a general formula (1-1); 3 wherein X, R1, R2, R3 and G1 are the same as defined in the description.
A medicinal composition characterized by comprising as the active ingredient either a compound represented by a general formula (1) or a pharmaceutically acceptable composite thereof;
An inhibitor of phospholipase A(2) activity comprising as the active ingredient at least one selected from a group consisting of heterocyclic compounds represented by the general formula (1) and the pharmaceutically acceptable composites thereof.
A use of a composition for a mammalian requiring remedy for inflammatory diseases or disorders, where the composition is characterized by containing as the active ingredient at least one selected from a group consisting of heterocyclic compounds represented by the general formula (1) and the pharmaceutically acceptable composites thereof.
A method to remedy or reduce inflammatory diseases or disorders, curing and/or preventing taking turn for the worth by administering a medicinal composition, which is comprising an effective dose of at least one selected from a group consisting of compounds represented by the general formula (1) and the pharmaceutically acceptable composites thereof to a mammalian requiring treatment.
A use of a heterocyclic derivative of the general formula (1) for manufacturing of a medicinal composition, which is used for reducing inflammatory and/or allergic sick condition and/or sick condition associated with immunity, and/or remedy from the diseases and disorders.
A use of a composition as a medicine, where the composition contains as the active ingredient at least one selected from a group consisting of heterocyclic derivatives represented by the general formula (1) and the pharmaceutically acceptable composites thereof.
Dependencies are inferred from the claim text.